Development of an End-user Informed Tenofovir Alafenamide (TAF) Implant for Long-acting (LA)-HIV Pre-exposure Prophylaxis (PrEP)
Gatto, G. J., Brand, R. M., Girouard, N., Li, L. A., Johnson, L., Marzinke, M. A., Krogstad, E., Siegel, A., Helms, E., Demkovich, Z., Luecke, E., & van der Straten, A. (2018). Development of an End-user Informed Tenofovir Alafenamide (TAF) Implant for Long-acting (LA)-HIV Pre-exposure Prophylaxis (PrEP). AIDS Research and Human Retroviruses, 34, 70.
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.
Meet the Experts
View All ExpertsRecent Publications
Article
Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults
Article
Epigenetic biomarkers for smoking cessation
Article
A pilot PT scheme for external assessment of laboratory performance in testing synthetic opioid compounds in urine, plasma, and whole blood
Article